Correlation Between Gensight Biologics and Integragen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gensight Biologics and Integragen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gensight Biologics and Integragen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gensight Biologics SA and Integragen, you can compare the effects of market volatilities on Gensight Biologics and Integragen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gensight Biologics with a short position of Integragen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gensight Biologics and Integragen.

Diversification Opportunities for Gensight Biologics and Integragen

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Gensight and Integragen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Gensight Biologics SA and Integragen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integragen and Gensight Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gensight Biologics SA are associated (or correlated) with Integragen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integragen has no effect on the direction of Gensight Biologics i.e., Gensight Biologics and Integragen go up and down completely randomly.

Pair Corralation between Gensight Biologics and Integragen

Assuming the 90 days trading horizon Gensight Biologics SA is expected to generate 1.8 times more return on investment than Integragen. However, Gensight Biologics is 1.8 times more volatile than Integragen. It trades about 0.0 of its potential returns per unit of risk. Integragen is currently generating about -0.06 per unit of risk. If you would invest  73.00  in Gensight Biologics SA on September 12, 2024 and sell it today you would lose (42.00) from holding Gensight Biologics SA or give up 57.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Gensight Biologics SA  vs.  Integragen

 Performance 
       Timeline  
Gensight Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gensight Biologics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Integragen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integragen has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Gensight Biologics and Integragen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gensight Biologics and Integragen

The main advantage of trading using opposite Gensight Biologics and Integragen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gensight Biologics position performs unexpectedly, Integragen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integragen will offset losses from the drop in Integragen's long position.
The idea behind Gensight Biologics SA and Integragen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance